| |
| |
|
| Insider
Information: |
Ragan Paula |
| Relationship: |
President and CEO, Dir... |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
765,068 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$746,630 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
765,068 |
|
|
| Total
Value |
$746,630 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
X4 Pharmaceuticals Inc |
XFOR |
President and CEO, Dir... |
2024-03-11 |
765,068 |
2019-03-13 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
43 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| XFOR |
X4 Pharmaceuticals Inc |
President and CEO |
• • – |
2019-03-13 |
4 |
A |
$0.00 |
$0 |
D/D |
181,366 |
181,366 |
0 |
- |
|
| XFOR |
X4 Pharmaceuticals Inc |
President and CEO |
• • – |
2019-06-17 |
4 |
A |
$0.00 |
$0 |
D/D |
55,928 |
237,294 |
0 |
- |
|
| XFOR |
X4 Pharmaceuticals Inc |
President and CEO |
• – – |
2020-03-02 |
4 |
AS |
$10.64 |
$25,536 |
D/D |
(2,400) |
234,894 |
0 |
% |
|
| XFOR |
X4 Pharmaceuticals Inc |
President and CEO |
• – – |
2020-04-02 |
4 |
AS |
$8.40 |
$20,160 |
D/D |
(2,400) |
232,494 |
0 |
% |
|
| XFOR |
X4 Pharmaceuticals Inc |
President and CEO |
• – – |
2020-05-04 |
4 |
AS |
$8.92 |
$21,408 |
D/D |
(2,400) |
230,094 |
0 |
% |
|
| XFOR |
X4 Pharmaceuticals Inc |
President and CEO |
• – – |
2020-06-01 |
4 |
AS |
$8.63 |
$36,893 |
D/D |
(4,275) |
225,819 |
0 |
% |
|
| XFOR |
X4 Pharmaceuticals Inc |
President and CEO |
• – – |
2020-06-02 |
4 |
AS |
$8.65 |
$20,760 |
D/D |
(2,400) |
223,419 |
0 |
% |
|
| XFOR |
X4 Pharmaceuticals Inc |
President and CEO |
• – – |
2020-06-03 |
4 |
AS |
$8.88 |
$86,198 |
D/D |
(9,707) |
213,712 |
0 |
% |
|
| XFOR |
X4 Pharmaceuticals Inc |
President and CEO |
• – – |
2020-07-02 |
4 |
AS |
$9.05 |
$21,720 |
D/D |
(2,400) |
211,312 |
0 |
% |
|
| XFOR |
X4 Pharmaceuticals Inc |
President and CEO |
• – – |
2020-08-03 |
4 |
AS |
$7.45 |
$17,880 |
D/D |
(2,400) |
208,912 |
0 |
% |
|
| XFOR |
X4 Pharmaceuticals Inc |
President and CEO |
• • – |
2020-08-14 |
4 |
A |
$0.00 |
$0 |
D/D |
44,826 |
253,738 |
0 |
- |
|
| XFOR |
X4 Pharmaceuticals Inc |
President and CEO |
• • – |
2020-08-17 |
4 |
A |
$0.00 |
$0 |
D/D |
44,825 |
298,563 |
0 |
- |
|
| XFOR |
X4 Pharmaceuticals Inc |
President and CEO |
• • – |
2020-09-02 |
4 |
AS |
$7.99 |
$19,176 |
D/D |
(2,400) |
296,163 |
0 |
% |
|
| XFOR |
X4 Pharmaceuticals Inc |
President and CEO |
• • – |
2020-09-09 |
4 |
AS |
$8.04 |
$71,074 |
D/D |
(8,840) |
287,323 |
0 |
% |
|
| XFOR |
X4 Pharmaceuticals Inc |
President and CEO |
• • – |
2020-10-02 |
4 |
AS |
$7.00 |
$4,221 |
D/D |
(603) |
286,720 |
0 |
% |
|
| XFOR |
X4 Pharmaceuticals Inc |
President and CEO |
• • – |
2020-10-05 |
4 |
AS |
$7.00 |
$12,579 |
D/D |
(1,797) |
284,923 |
0 |
% |
|
| XFOR |
X4 Pharmaceuticals Inc |
President and CEO |
• • – |
2020-12-23 |
4 |
AS |
$7.00 |
$33,600 |
D/D |
(4,800) |
280,123 |
0 |
% |
|
| XFOR |
X4 Pharmaceuticals Inc |
President and CEO |
• • – |
2021-01-05 |
4 |
AS |
$7.00 |
$16,800 |
D/D |
(2,400) |
277,723 |
0 |
% |
|
| XFOR |
X4 Pharmaceuticals Inc |
President and CEO |
• • – |
2021-02-02 |
4 |
AS |
$7.88 |
$18,912 |
D/D |
(2,400) |
275,323 |
0 |
% |
|
| XFOR |
X4 Pharmaceuticals Inc |
President and CEO |
• • – |
2021-03-02 |
4 |
AS |
$9.74 |
$23,376 |
D/D |
(2,400) |
272,923 |
0 |
% |
|
| XFOR |
X4 Pharmaceuticals Inc |
President and CEO |
• • – |
2021-03-24 |
4 |
A |
$0.00 |
$0 |
D/D |
144,629 |
417,552 |
0 |
- |
|
| XFOR |
X4 Pharmaceuticals Inc |
President and CEO |
• • – |
2021-04-05 |
4 |
AS |
$9.17 |
$22,008 |
D/D |
(2,400) |
415,152 |
0 |
% |
|
| XFOR |
X4 Pharmaceuticals Inc |
President and CEO |
• • – |
2021-05-03 |
4 |
AS |
$8.33 |
$19,992 |
D/D |
(2,400) |
412,752 |
0 |
% |
|
| XFOR |
X4 Pharmaceuticals Inc |
President and CEO |
• • – |
2021-06-01 |
4 |
AS |
$9.41 |
$38,619 |
D/D |
(4,104) |
408,648 |
0 |
% |
|
| XFOR |
X4 Pharmaceuticals Inc |
President and CEO |
• • – |
2021-06-02 |
4 |
AS |
$9.50 |
$22,800 |
D/D |
(2,400) |
406,248 |
0 |
% |
|
43 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
